S-Bank Fund Management’s Edwards Lifesciences EW Stock Holding History

S-Bank Fund Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$501K	Buy	+5,533	New	+$464K	0.07%	150

Other funds holding EW

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 41.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

S-Bank Fund Management's EW Position: Q2 2026 in Review

S-Bank Fund Management opened a new position in Edwards Lifesciences (EW) in Q2 2026: 5,533 shares worth $501K. The stake represents 0.07% of the portfolio and ranks #150 among its holdings.

684 funds tracked by Wall St. Rank hold EW as of Q2 2026.

S-Bank Fund Management held 5,533 shares of Edwards Lifesciences worth $501K as of Q2 2026.
Edwards Lifesciences was a new S-Bank Fund Management position in Q2 2026.
Edwards Lifesciences made up 0.07% of S-Bank Fund Management's portfolio in Q2 2026, its #150 holding.
684 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on S-Bank Fund Management's 13F filing for Q2 2026, filed 4 Aug 2026.